Amelia Ruth Hofstetter
5PUBLICATIONS
34CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 17, 2024
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine.Joseph P Casazza, Amelia R Hofstetter, Pamela J M Costner
|Mar 30, 2024
Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase 1/1b trials.Myra Happe, Amelia R Hofstetter, Jing Wang
|Apr 19, 2023
An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults.Alicia T Widge, Amelia R Hofstetter, Katherine V Houser
|Feb 04, 2022
Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.Katherine V Houser, Grace L Chen, Cristina Carter
|Dec 23, 2017
Monitoring bottlenose dolphin leukocyte cytokine mRNA responsiveness by qPCR.Amelia Ruth Hofstetter, Kirsten C Eberle, Stephanie K Venn-Watson
Pageof 1
Frequent Collaborators
4 joint publications
Katherine V Houser
3 joint publications
Masaru Kanekiyo
3 joint publications
Sarah F Andrews
3 joint publications
Adrian B McDermott
2 joint publications
Rebecca A Gillespie
2 joint publications
Adrian Creanga
2 joint publications
Raffael Nachbagauer
2 joint publications
Peter Palese
2 joint publications
Mike Castro
2 joint publications
Jason G Gall
